What happens when CLL drugs stop working? new study investigates

NCT ID NCT05621148

First seen Jan 05, 2026 · Last updated May 17, 2026 · Updated 21 times

Summary

This study looked at 152 adults with chronic lymphocytic leukemia (CLL) whose cancer stopped responding to targeted drugs like ibrutinib and venetoclax. Researchers collected data on which treatments were used next and how well they worked. The goal was to understand the best ways to treat patients when standard therapies fail.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL LYMPHOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Bordeaux Pessac

    Pessac, 33604, France

  • CHU Estaing - Hématologie Clinique Adulte

    Clermont-Ferrand, 63000, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495, France

  • Centre Léon Bérard - Hématologie

    Lyon, 69373, France

  • Institut Paoli-Calmettes - Hématologie Clinique

    Marseille, 13273, France

  • MONTPELLIER - Hôpital Saint-Eloi - Hématologie Clinique

    Montpellier, 34295, France

  • Strasbourg - Icans

    Strasbourg, 67033, France

  • Toulouse - IUCT Oncopole - Service d'Hématologie

    Toulouse, 31059, France

Conditions

Explore the condition pages connected to this study.